Fexolead-M Tablet is a combination medication containing Montelukast 10mg and Fexofenadine 120mg, designed to provide effective relief from allergic conditions. Montelukast is a leukotriene receptor antagonist that works by blocking substances called leukotrienes, which cause inflammation, bronchoconstriction, and mucus production in the airways. Fexofenadine is a second-generation antihistamine that selectively blocks peripheral H1 receptors, reducing symptoms such as sneezing, runny nose, itchy or watery eyes, and hives without causing significant drowsiness. Together, these active ingredients offer a comprehensive approach to managing allergic rhinitis, chronic urticaria, and other allergic manifestations by targeting multiple pathways involved in allergic responses. Fexolead-M is typically prescribed for patients who require both leukotriene receptor antagonism and antihistamine effects to control their symptoms effectively. It is important to take this medication as directed by a healthcare professional, usually once daily, preferably in the evening. Common side effects may include headache, dizziness, or gastrointestinal discomfort, but it is generally well tolerated. Patients with liver impairment or those taking other medications should consult their doctor before use. Fexolead-M Tablet is a valuable option for improving quality of life in individuals suffering from persistent allergic conditions.